|
US4036964A
(en)
|
1973-10-11 |
1977-07-19 |
Beecham Group Limited |
Isocarbostyril-3-carboxylic acid derivatives for the prophylaxis of asthma, hayfever and rhinitis
|
|
US3989704A
(en)
|
1973-10-30 |
1976-11-02 |
Sandoz, Inc. |
3-Substituted-4-aryl isoquinolines
|
|
DE2818423A1
(de)
|
1978-04-27 |
1979-11-08 |
Hoechst Ag |
Neue isochinolinderivate und verfahren zu ihrer herstellung
|
|
DE3233424A1
(de)
|
1982-09-09 |
1984-03-15 |
Hoechst Ag, 6230 Frankfurt |
Isochinolinderivate, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung
|
|
US4559403A
(en)
|
1983-05-19 |
1985-12-17 |
Hoffmann-La Roche Inc. |
Substituted isoquinolines
|
|
US4584379A
(en)
|
1985-01-22 |
1986-04-22 |
Merrell Dow Pharmaceuticals Inc. |
Isoquinoline thromboxane synthetase inhibitors
|
|
US4822800A
(en)
|
1986-06-09 |
1989-04-18 |
Ortho Pharmaceutical Corporation |
Isoquinolinol compounds having cardiotonic and phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties
|
|
US4952588A
(en)
|
1987-11-27 |
1990-08-28 |
Hoechst-Roussel Pharmaceuticals Inc. |
1-aryl-3-quinoline-and 1-aryl-3-isoquinoline-carboxamides
|
|
US4966906A
(en)
|
1987-11-27 |
1990-10-30 |
Hoechst-Roussel Pharmaceuticals Inc. |
1-aryl-3-isoquinolinecarboxamides
|
|
EP0532466A3
(en)
|
1991-09-12 |
1993-06-16 |
Ciba-Geigy Ag |
Derivatives of 5-amino-4-hydroxy-hexanoic acid and their therapeutical use
|
|
EP0626178A1
(de)
|
1993-05-17 |
1994-11-30 |
Ciba-Geigy Ag |
Verwendung von Hemmstoffen von HIV-Aspartatproteasen zur Bekämpfung von Tumorerkrankungen
|
|
ES2101420T3
(es)
|
1993-11-02 |
1997-07-01 |
Hoechst Ag |
Esteres-amidas de acidos carboxilicos heterociclicos sustituidos, su preparacion y su utilizacion como medicamentos.
|
|
EP0650961B1
(de)
|
1993-11-02 |
1997-03-05 |
Hoechst Aktiengesellschaft |
Substituierte heterocyclische Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
|
|
NZ270267A
(en)
|
1993-12-30 |
1997-03-24 |
Hoechst Ag |
3-hydroxypyridin-2yl (and -quinolin-2-yl) carboxamide derivatives and pharmaceutical compositions
|
|
US5563143A
(en)
|
1994-09-21 |
1996-10-08 |
Pfizer Inc. |
Catechol diether compounds as inhibitors of TNF release
|
|
AU4515696A
(en)
|
1994-12-12 |
1996-07-03 |
Merck & Co., Inc. |
Substituted 2-aminopyridines as inhibitors of nitric oxide synthase
|
|
IL135495A
(en)
|
1995-09-28 |
2002-12-01 |
Hoechst Ag |
Intermediate compounds for the preparation of quinoline-converted amines - 2 - carboxylic acid
|
|
WO1998023608A1
(en)
|
1996-11-27 |
1998-06-04 |
Dupont Pharmaceuticals Company |
Novel integrin receptor antagonists
|
|
GB9707830D0
(en)
|
1997-04-18 |
1997-06-04 |
Smithkline Beecham Plc |
Novel compounds
|
|
AU7526798A
(en)
|
1997-04-18 |
1998-11-27 |
Smithkline Beecham Plc |
Acetamide and urea derivatives, process for their preparation and their use in the treatment of cns disorders
|
|
DE19746287A1
(de)
|
1997-10-20 |
1999-04-22 |
Hoechst Marion Roussel De Gmbh |
Substituierte Isochinolin-2-Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
|
|
FR2779963A1
(fr)
|
1998-06-22 |
1999-12-24 |
Centre Nat Rech Scient |
Utilisation d'un compose possedant une affinite pour le recepteur mitochondrial des benzodiazepines en therapie du cancer
|
|
IT1302677B1
(it)
|
1998-10-15 |
2000-09-29 |
Zambon Spa |
Derivati benzazinici inibitori della fosfodiesterasi 4
|
|
WO2000064877A1
(en)
|
1999-04-26 |
2000-11-02 |
Neurogen Corporation |
2-aminoquinolinecarboxamides: neurokinin receptor ligands
|
|
IT1320162B1
(it)
|
2000-02-09 |
2003-11-18 |
Rotta Research Lab |
Derivati della tirosina ad attivita' anti leucotrienica, procedimentoper la loro preparazione e loro uso farmaceutico.
|
|
US7622503B2
(en)
|
2000-08-24 |
2009-11-24 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators and methods of use thereof
|
|
FI20002044A0
(fi)
|
2000-09-15 |
2000-09-15 |
Orion Yhtymae Oyj |
Comt-entsyymiä estäviä naftaleenijohdannaisia
|
|
DE10110750A1
(de)
|
2001-03-07 |
2002-09-12 |
Bayer Ag |
Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
|
|
JP4590157B2
(ja)
|
2001-03-21 |
2010-12-01 |
アイシス イノヴェイション リミテッド |
アッセイ、方法および手段
|
|
US6716866B2
(en)
|
2001-06-13 |
2004-04-06 |
Genesoft Pharmaceuticals, Inc. |
Aryl-benzimidazole compounds having antiinfective activity
|
|
US6777425B2
(en)
|
2001-06-13 |
2004-08-17 |
Genesoft Pharmaceuticals, Inc. |
Isoquinoline compounds having antiinfective activity
|
|
CA2448737C
(en)
|
2001-07-20 |
2010-06-01 |
Boehringer Ingelheim (Canada) Ltd. |
Viral polymerase inhibitors
|
|
EP2335700A1
(en)
|
2001-07-25 |
2011-06-22 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis C virus polymerase inhibitors with a heterobicylic structure
|
|
US7294457B2
(en)
|
2001-08-07 |
2007-11-13 |
Boehringer Ingelheim (Canada) Ltd. |
Direct binding assay for identifying inhibitors of HCV polymerase
|
|
US6762318B2
(en)
|
2001-12-03 |
2004-07-13 |
Novo Nordisk A/S |
Glucagon antagonists
|
|
CN102552263A
(zh)
|
2001-12-06 |
2012-07-11 |
法布罗根股份有限公司 |
提高内源性红细胞生成素(epo)的方法
|
|
GB0206711D0
(en)
|
2002-03-21 |
2002-05-01 |
Isis Innovation |
HIF Inhibitor
|
|
US7618940B2
(en)
|
2002-12-06 |
2009-11-17 |
Fibrogen, Inc. |
Fat regulation
|
|
US8124582B2
(en)
|
2002-12-06 |
2012-02-28 |
Fibrogen, Inc. |
Treatment of diabetes
|
|
US8614204B2
(en)
|
2003-06-06 |
2013-12-24 |
Fibrogen, Inc. |
Enhanced erythropoiesis and iron metabolism
|
|
CA2528232C
(en)
|
2003-06-06 |
2010-05-25 |
Fibrogen, Inc. |
Novel nitrogen-containing heteroaryl compounds and their use in increasing endogenous erythropoietin
|
|
WO2005007192A2
(en)
|
2003-06-06 |
2005-01-27 |
Fibrogen, Inc. |
Cytoprotection through the use of hif hydroxylase inhibitors
|
|
CN100418948C
(zh)
|
2003-07-15 |
2008-09-17 |
麦克公司 |
羟基吡啶cgrp受体抗拮抗剂
|
|
US7208601B2
(en)
|
2003-08-08 |
2007-04-24 |
Mjalli Adnan M M |
Aryl and heteroaryl compounds, compositions, and methods of use
|
|
WO2005014533A2
(en)
|
2003-08-08 |
2005-02-17 |
Transtech Pharma, Inc. |
Aryl and heteroaryl compounds, compositions, and methods of use
|
|
KR20070041720A
(ko)
|
2004-07-15 |
2007-04-19 |
파워프리사이스 솔루션즈, 인코포레이티드 |
1 회 작동 상태 검출 방법 및 장치
|
|
EP1676834A1
(en)
|
2004-12-30 |
2006-07-05 |
Sanofi-Aventis Deutschland GmbH |
Fused bicyclic carboxamide derivates for use as CXCR2 inhibitors in the treatment of inflammation
|
|
WO2006094292A2
(en)
|
2005-03-02 |
2006-09-08 |
Fibrogen, Inc. |
Thienopyridine compounds, and methods of use thereof
|
|
US20060276477A1
(en)
|
2005-06-06 |
2006-12-07 |
Fibrogen, Inc. |
Treatment method for anemia
|
|
AU2006259352A1
(en)
|
2005-06-15 |
2006-12-28 |
Fibrogen, Inc. |
Use of HIF 1alfa modulators for treatment of cancer
|
|
EP2476669A1
(en)
|
2006-01-27 |
2012-07-18 |
Fibrogen, Inc. |
Cyanoisoquinoline compounds and methods of use thereof
|
|
US20070259960A1
(en)
*
|
2006-02-16 |
2007-11-08 |
Fibrogen, Inc. |
Compounds and methods for treatment of stroke
|
|
CN103497184A
(zh)
|
2006-04-04 |
2014-01-08 |
菲布罗根有限公司 |
作为hif调节剂的吡咯并吡啶和噻唑并吡啶化合物
|
|
US7713986B2
(en)
|
2006-06-15 |
2010-05-11 |
Fibrogen, Inc. |
Compounds and methods for treatment of chemotherapy-induced anemia
|
|
US20070293575A1
(en)
|
2006-06-15 |
2007-12-20 |
Fibrogen, Inc. |
Compounds and methods for treatment of cancer-related anemia
|
|
WO2009075826A1
(en)
*
|
2007-12-07 |
2009-06-18 |
Fibrogen, Inc. |
Methods for increasing white blood cells
|
|
CA2899024C
(en)
|
2013-01-24 |
2022-01-04 |
Fibrogen, Inc. |
Crystalline forms of {[1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-acetic acid
|